NP-101

· Novatek Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NP-101, covering 2025-05-22 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Results: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. [Phase 2]

See pricing